Zhifei Xu

2.4k total citations
101 papers, 1.7k citations indexed

About

Zhifei Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Zhifei Xu has authored 101 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 28 papers in Pulmonary and Respiratory Medicine and 25 papers in Surgery. Recurrent topics in Zhifei Xu's work include Esophageal Cancer Research and Treatment (9 papers), Autophagy in Disease and Therapy (9 papers) and PI3K/AKT/mTOR signaling in cancer (8 papers). Zhifei Xu is often cited by papers focused on Esophageal Cancer Research and Treatment (9 papers), Autophagy in Disease and Therapy (9 papers) and PI3K/AKT/mTOR signaling in cancer (8 papers). Zhifei Xu collaborates with scholars based in China, United States and South Korea. Zhifei Xu's co-authors include Peihua Luo, Qiaojun He, Hao Yan, Bo Yang, Xiaochun Yang, Jingying Li, Ying Jin, Jian Chen, Xuewei Zhao and Wen Yang and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and PLoS ONE.

In The Last Decade

Zhifei Xu

92 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhifei Xu China 25 763 330 322 288 193 101 1.7k
Tamara Howard United States 19 734 1.0× 248 0.8× 199 0.6× 357 1.2× 225 1.2× 37 1.7k
Fabien Milliat France 26 609 0.8× 495 1.5× 513 1.6× 308 1.1× 239 1.2× 92 2.0k
Lian Duan China 20 536 0.7× 199 0.6× 266 0.8× 218 0.8× 174 0.9× 160 1.6k
Seiji Kishi Japan 20 1.1k 1.4× 334 1.0× 151 0.5× 304 1.1× 101 0.5× 64 1.8k
Gang Deng China 26 667 0.9× 426 1.3× 354 1.1× 351 1.2× 453 2.3× 90 1.9k
Min Mao China 27 723 0.9× 561 1.7× 485 1.5× 281 1.0× 394 2.0× 105 1.8k
Taku Kato Japan 21 824 1.1× 358 1.1× 233 0.7× 248 0.9× 521 2.7× 133 1.6k
Jinming Xu China 25 563 0.7× 454 1.4× 407 1.3× 226 0.8× 356 1.8× 82 1.9k

Countries citing papers authored by Zhifei Xu

Since Specialization
Citations

This map shows the geographic impact of Zhifei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhifei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhifei Xu more than expected).

Fields of papers citing papers by Zhifei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhifei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhifei Xu. The network helps show where Zhifei Xu may publish in the future.

Co-authorship network of co-authors of Zhifei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhifei Xu. A scholar is included among the top collaborators of Zhifei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhifei Xu. Zhifei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Hao, et al.. (2025). The inducible role of autophagy in cell death: emerging evidence and future perspectives. Cell Communication and Signaling. 23(1). 151–151. 12 indexed citations
2.
Yin, Yiming, et al.. (2025). Mechanism and therapeutic potential of liver injury induced by cholesterol-associated proteins. Frontiers in Pharmacology. 16. 1572592–1572592. 2 indexed citations
3.
Yan, Hao, Mu Yuan, Zhifei Xu, et al.. (2025). Disturbing Cholesterol/Sphingolipid Metabolism by Squalene Epoxidase Arises Crizotinib Hepatotoxicity. Advanced Science. 12(14). e2414923–e2414923. 2 indexed citations
4.
Xu, Zhifei, et al.. (2024). Nanoselenium foliar application boosts antioxidant capacity and soluble solids in kiwifruit. Scientia Horticulturae. 337. 113521–113521. 6 indexed citations
5.
Cheng, Mengting, Fei Wang, Zhifei Xu, et al.. (2024). Underlying mechanisms and management strategies for regorafenib-induced toxicity in hepatocellular carcinoma. Expert Opinion on Drug Metabolism & Toxicology. 20(9). 907–922.
6.
Xu, Zhifei, Bo Yang, Qiaojun He, et al.. (2023). An update on Alectinib: a first line treatment for ALK-positive advanced lung cancer. Expert Opinion on Pharmacotherapy. 24(12). 1361–1373. 1 indexed citations
7.
Yan, Hao, Jinjin Li, Xueqin Chen, et al.. (2023). Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK/MDM2/p53 axis. Nature Communications. 14(1). 2756–2756. 31 indexed citations
8.
Yan, Hao, Ying Zhang, Jiajia Chen, et al.. (2023). Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13‐Mediated Stabilization of Bcl‐XL. Advanced Science. 10(26). e2302002–e2302002. 9 indexed citations
9.
Jiang, Liyu, Yan Zeng, Hao Yan, et al.. (2022). Decreased HMGB1 expression contributed to cutaneous toxicity caused by lapatinib. Biochemical Pharmacology. 201. 115105–115105. 9 indexed citations
10.
11.
Xu, Zhifei, Ying Jin, Yan Zeng, et al.. (2021). Autophagic degradation of CCN2 (cellular communication network factor 2) causes cardiotoxicity of sunitinib. Autophagy. 18(5). 1152–1173. 44 indexed citations
12.
Wang, Zeng, Liyu Jiang, Hao Yan, Zhifei Xu, & Peihua Luo. (2021). Adverse events associated with nilotinib in chronic myeloid leukemia: mechanisms and management strategies. Expert Review of Clinical Pharmacology. 14(4). 445–456. 14 indexed citations
13.
Yan, Hao, Zhifei Xu, Bo Yang, et al.. (2021). Cutaneous toxicity of FDA-approved small-molecule kinase inhibitors. Expert Opinion on Drug Metabolism & Toxicology. 17(11). 1311–1325. 6 indexed citations
14.
Chen, Jian, Hao Yan, Qiaojun He, et al.. (2020). <p>Research Status and Outlook of PD-1/PD-L1 Inhibitors for Cancer Therapy</p>. Drug Design Development and Therapy. Volume 14. 3625–3649. 139 indexed citations
15.
Jiang, Liyu, Ping Li, Hao Yan, et al.. (2020). Cardiovascular toxicity induced by anti-VEGF/VEGFR agents: a special focus on definitions, diagnoses, mechanisms and management. Expert Opinion on Drug Metabolism & Toxicology. 16(9). 823–835. 16 indexed citations
16.
Jiang, Liyu, et al.. (2020). COVID-19 epidemic: a special focus on diagnosis, complications, and management. Expert Review of Clinical Pharmacology. 13(10). 1085–1093. 2 indexed citations
17.
Chen, Shan, Zhifei Xu, Wen Yang, et al.. (2019). Logic‐Gate‐Actuated DNA‐Controlled Receptor Assembly for the Programmable Modulation of Cellular Signal Transduction. Angewandte Chemie International Edition. 58(50). 18186–18190. 107 indexed citations
18.
Xu, Zhifei, Ying Jin, Hao Yan, et al.. (2018). High-mobility group box 1 protein-mediated necroptosis contributes to dasatinib-induced cardiotoxicity. Toxicology Letters. 296. 39–47. 40 indexed citations
19.
Nie, Wei, Aijun Ding, Y. N. Xie, et al.. (2015). Influence of biomass burning plumes on HONO chemistry in eastern China. Atmospheric chemistry and physics. 15(3). 1147–1159. 111 indexed citations
20.
Tang, Hua, Qin Xiong, Lei Xue, et al.. (2012). A portable thoracic closed drainage instrument for hemopneumothorax. The Journal of Trauma: Injury, Infection, and Critical Care. 72(3). 671–675. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamara Howard Breakdown of academic impact, for papers by Fabien Milliat Breakdown of academic impact, for papers by Lian Duan Breakdown of academic impact, for papers by Seiji Kishi Breakdown of academic impact, for papers by Gang Deng Breakdown of academic impact, for papers by Min Mao Breakdown of academic impact, for papers by Taku Kato Breakdown of academic impact, for papers by Jinming Xu
Rankless by CCL
2026